Clinical Trials Logo

Clinical Trial Summary

Effective post-operative pain control can reduce patient morbidity and affect the patient outcome. Brachial plexus block is one of them, a popular and widely employed regional nerve block technique for perioperative anesthesia and analgesia for surgery of the upper extremity.

Different drugs have been used as adjuvants with local anesthetics in brachial plexus block to achieve quick, dense and prolonged block like Morphine, Pethidine, Clonidine, Dexmedetomidine.

Naloxone is opioid antagonists which could selectively block the excitatory effects of opioids. it release endorphins and also displace endorphins from receptor site .it also reduce the opioid induced side effects, such as vomiting, nausea, pruritus, and respiratory depression.


Clinical Trial Description

The aim of this study is to evaluate the effect of ultra-low dose of naloxone when added to bupivacaine %.05 in supraclavicular brachial plexus block in orthopedic upper limb surgery and if it enhances the anti-nociceptive effect of post-operative opioid

Effect of naloxone on anti-nociceptive criteria of post -operative opioid will be estimated by detecting the interval between each analgesic dose of post-operative opioid. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03372486
Study type Interventional
Source Mansoura University
Contact
Status Completed
Phase N/A
Start date December 18, 2017
Completion date April 25, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05422014 - Upper Extremity Life Care Specialist (LCS) N/A
Withdrawn NCT04764578 - Sexual Dysfunction Following Upper Extremity Trauma